June 19, 2019
INVRAGEN (INV-DEN-203)
A double-blind, randomized, placebo-controlled, age descending and expansion Phase 2 study to investigate the safety…
Read More
June 19, 2019
AMGEN (20100761)
A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG…
Read More
June 19, 2019
TAKEDA
A Double-Blind, Randomized, Placebo-Controlled, 5-Arm Titration Study to Evaluate the Efficacy and Safety of TAK-491…
Read More
June 19, 2019
PFIZER (CV185056)
A Safety and Efficacy Trial Evaluating The Use Of Apixaban In The Treatment Of Symptomatic…
Read More
June 19, 2019
PFIZER (CV185057)
A Safety and Efficacy Trial Evaluating The Use Of Apixaban For The Extended Treatment Of…
Read More
June 19, 2019
NOVARTIS
An 8-week Multicenter, Randomized, Double-blind, Active Controlled, Parallel Group, and Forced Titration Study to Evaluate…
Read More
June 19, 2019
ABBOTT (L-CP07-167)
A Phase 3, Randomized, Multi-Center, Open-Label Study To Evaluate the Efficacy and Safety of Leuprolide…
Read More
June 19, 2019
TAKEDA
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment with Alogliptin in…
Read More
June 19, 2019
J&J (DIA3006)
A Randomized, Double-Blind, Placebo and Active-Controlled, 4-Arm, Parallel- Group, Multicenter Study Evaluate the Efficacy, Safety,…
Read More
